mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.07 |
mRNA |
JW-7-24-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.057 |
0.08 |
mRNA |
masitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.062 |
0.08 |
mRNA |
Cytarabine |
GDSC1000 |
pan-cancer |
AAC |
-0.068 |
0.08 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.08 |
mRNA |
Gemcitabine |
GDSC1000 |
pan-cancer |
AAC |
-0.066 |
0.08 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.08 |
mRNA |
Salubrinal |
GDSC1000 |
pan-cancer |
AAC |
-0.096 |
0.08 |
mRNA |
VNLG/124 |
GDSC1000 |
pan-cancer |
AAC |
-0.061 |
0.08 |
mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.08 |